USCOM 

Globally, Uscom Limited specializes in the creation, production, and distribution of non-intrusive medical instruments for assessing heart and lung health. Its product portfolio includes the USCOM 1A, a device utilizing Doppler ultrasound to non-invasively assess hemodynamic and cardiovascular performance. Also available is the BP+, a central blood pressure monitor employing supra-systolic oscillometry to gauge blood pressure and its waveforms both centrally (at the heart) and peripherally (in the arm). The company also produces the SpiroSonic, an ultrasound-based multi-path system for evaluating pulmonary function. Further expanding its offerings, Uscom presents the SpiroSonic AIR, a digital multipath ultrasonic spirometer featuring an integrated viral disinfection system capable of neutralizing pathogens like COVID and tuberculosis, alongside other respiratory equipment. Uscom's solutions are delivered to hospitals and various healthcare facilities via a broad network of distribution alliances. Established in 1999, the firm initially operated as Uscom Pty Limited before adopting the name Uscom Limited in October 2003. Its main corporate office is situated in Sydney, Australia.